Separate indirect from direct design evidence (SIDDE)

Fixed effects model: 

             comparison k  nma direct indir. RoR z p-value
 BZD-short:daridorexant 0 2.55      .   2.55   . .       .
      BZD-short:placebo 1 1.71   1.71      .   . .       .
     BZD-short:zaleplon 0 1.27      .   1.27   . .       .
     BZD-short:zolpidem 0 1.25      .   1.25   . .       .
   daridorexant:placebo 0 0.67      .   0.67   . .       .
  daridorexant:zaleplon 0 0.50      .   0.50   . .       .
  daridorexant:zolpidem 1 0.49   0.49      .   . .       .
       zaleplon:placebo 1 1.34   1.34      .   . .       .
       zolpidem:placebo 1 1.37   1.37      .   . .       .
      zaleplon:zolpidem 1 0.98   0.98      .   . .       .

Legend:
 comparison - Treatment comparison
 k          - Number of studies providing direct evidence
 nma        - Estimated treatment effect (OR) in network meta-analysis
 direct     - Estimated treatment effect (OR) derived from direct evidence
 indir.     - Estimated treatment effect (OR) derived from indirect evidence
 RoR        - Ratio of Ratios (direct versus indirect)
 z          - z-value of test for disagreement (direct versus indirect)
 p-value    - p-value of test for disagreement (direct versus indirect)
[1] "Percent of comparisons where there is some evidence (p-value<0.05) of disagreement between direct and indirect sources: NaN. (0 out of 0 comparisons)."
[1] "File created on 2022-06-09"
